Results 211 to 220 of about 68,288 (264)

<i>BRCA</i> and CDK4/6: allies or antagonists?-efficacy of CDK4/6 inhibitors in HR<sup>+</sup>/HER2<sup>-</sup> breast cancer with germline <i>BRCA1/2</i> mutations: a narrative review. [PDF]

open access: yesTransl Breast Cancer Res
Illia MF   +11 more
europepmc   +1 more source

Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women

open access: yesJournal of the National Cancer Institute, 2018
R. Manchanda   +14 more
semanticscholar   +1 more source

Novel Insights into the Enigmatic Genetics of Male Breast Cancer in China. [PDF]

open access: yesPathophysiology
Lang GT   +5 more
europepmc   +1 more source

Decisional conflict in women with a BRCA1 or BRCA2 pathogenic variant who have not elected for risk-reducing salpingo-oophorectomy. [PDF]

open access: yesHered Cancer Clin Pract
Metcalfe KA   +7 more
europepmc   +1 more source

Germline genetic profiling utilizing multigene panel testing in Jordanian patients with pancreatic cancer: a comprehensive cancer center experience. [PDF]

open access: yesBMC Cancer
Abdel-Razeq H   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy